Recombinant Litoria ewingi Uperin-7.1

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the available format, but if you have specific format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specifics. Proteins are shipped with blue ice packs. Request dry ice in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us.
Synonyms
; Uperin-7.1 [Cleaved into: Uperin-7.1.1]
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-13
Protein Length
Cytoplasmic domain
Purity
>85% (SDS-PAGE)
Species
Litoria ewingii (Brown tree frog) (Ewing's tree frog)
Target Protein Sequence
GWFDVVKHIA SAV
Uniprot No.

Target Background

Function
Uperin 7.1 exhibits antibacterial activity against L. lactis and S. uberis. Uperin 7.1.1 is inactive.
Subcellular Location
Secreted.
Tissue Specificity
Expressed by the skin dorsal glands.

Q&A

What is Uperin-7.1 and what makes it significant among amphibian skin peptides?

Uperin-7.1 is one of the key antimicrobial peptides identified in the skin secretions of Litoria ewingi (brown tree frog), a relatively widespread pelodryadid frog from south-eastern Australia. It belongs to a broader family of host-defense peptides secreted by amphibian skin glands. What makes Uperin-7.1 particularly interesting is its presence within a complex mixture of at least 12 other unidentified peptides in L. ewingi skin secretions, suggesting it plays a role in the species' defense mechanisms .

The peptide is significant because it exemplifies the diversity of amphibian skin peptides that have evolved as part of these animals' adaptation to terrestrial environments. Contemporary research suggests that such peptides may serve dual functions—not only as antimicrobial agents protecting the moist skin against pathogens but potentially also as cytolysins that may assist neuroactive peptides in antipredator roles .

How is the granular gland structure of Litoria ewingi related to Uperin-7.1 production?

The granular glands in Litoria ewingi display a distinctive ultrastructure that differs from closely related species such as L. aurea and L. raniformis. While all three species have granular glands distributed evenly across both dorsal and ventral skin surfaces, L. ewingi possesses a unique granular morphology consisting of homogeneous substructures with miniscule vesicles that are either electron opaque or diaphanous .

This distinctive glandular architecture in L. ewingi corresponds to its specific peptide secretion profile, including Uperin-7.1. The glands operate via a contractile myoepithelium surrounding the syncytial secretory unit, which releases peptides when stimulated by either norepinephrine or mild electric stimulation . Understanding this relationship between gland structure and peptide production is fundamental to designing effective extraction and recombinant production strategies.

What expression systems are most suitable for recombinant Uperin-7.1 production?

For recombinant Uperin-7.1 production, researchers should consider several expression systems based on the peptide's characteristics:

The optimal choice depends on specific research goals, such as whether native biological activity is essential or if modified variants are being studied. Regardless of the system, constructs typically require optimization of codon usage, signal peptides, and purification tags for successful expression.

What standardized methods exist for evaluating the antimicrobial activity of recombinant Uperin-7.1?

Standard methodologies for evaluating antimicrobial activity of recombinant Uperin-7.1 include:

  • Minimum Inhibitory Concentration (MIC) assays: Quantifies the lowest concentration of the peptide that prevents visible growth of microorganisms.

  • Time-kill kinetics: Evaluates how quickly the peptide eliminates microorganisms at various concentrations.

  • Membrane permeabilization assays: Using fluorescent dyes to assess how the peptide disrupts cell membranes, a common mechanism for antimicrobial peptides.

  • Hemolytic assays: Critical for measuring potential toxicity against mammalian cells, comparing antimicrobial potency versus hemolytic activity.

Researchers should establish standardized protocols that allow for consistent comparison between studies, as differences in experimental conditions can significantly impact measured activities.

How does the genetic diversity across Litoria ewingi populations impact Uperin-7.1 sequence variation?

Recent systematic assessments of Litoria ewingi have revealed deep phylogenetic structure between fragmented populations, with analyses of nuclear and mitochondrial DNA identifying distinct lineages, particularly in South Australia . This genetic diversity raises important questions about potential variation in the Uperin-7.1 sequence across different populations.

Researchers investigating recombinant Uperin-7.1 should consider:

  • Analyzing samples from multiple geographic locations to establish if there are region-specific variants

  • Correlating sequence variations with habitat-specific adaptations

  • Examining whether newly recognized species (Litoria calliscelis and Litoria sibilus) produce Uperin-7.1 variants with different properties

This geographical and species-level variation could yield peptide variants with different antimicrobial efficacy or target specificity, potentially expanding the therapeutic utility of Uperin-7.1-derived peptides.

What structure-function relationships guide the optimization of recombinant Uperin-7.1 variants?

When designing optimized variants of recombinant Uperin-7.1, researchers should consider several structure-function principles that affect antimicrobial activity:

Structural FeatureFunctional ImpactOptimization Strategy
Net positive chargeDetermines initial electrostatic interaction with negatively charged microbial membranesModifying lysine/arginine content to alter charge distribution
AmphipathicityInfluences membrane insertion and disruption capabilityAdjusting hydrophobic moment through targeted amino acid substitutions
HydrophobicityAffects depth of membrane penetrationTuning the hydrophobic/hydrophilic balance through strategic mutations
α-helical propensityRelates to conformational stability and activityIntroducing helix-stabilizing residues at key positions

Systematic modification of these parameters through site-directed mutagenesis allows researchers to develop Uperin-7.1 variants with enhanced antimicrobial specificity, reduced cytotoxicity against mammalian cells, or improved stability against proteolytic degradation.

How can contradictions in activity data between native and recombinant Uperin-7.1 be reconciled?

Researchers frequently encounter discrepancies between the activity profiles of native Uperin-7.1 isolated directly from Litoria ewingi and recombinant versions. These contradictions typically arise from:

  • Post-translational modifications: Native peptides may undergo modifications absent in recombinant systems

  • Structural variations: Subtle differences in folding or conformation between native and recombinant forms

  • Synergistic effects: Natural skin secretions contain multiple peptides that may work synergistically, whereas recombinant studies typically isolate single peptides

  • Methodological differences: Variations in antimicrobial testing protocols between studies

To reconcile these contradictions, researchers should implement parallel testing of native and recombinant peptides using identical assay conditions, conduct detailed structural analyses using circular dichroism and NMR spectroscopy, and consider the natural context of Uperin-7.1 as part of a broader peptide mixture with potential cooperative antimicrobial effects.

What are the optimal conditions for studying membrane interactions of recombinant Uperin-7.1?

Given that many amphibian antimicrobial peptides function through membrane disruption mechanisms, studying the membrane interactions of recombinant Uperin-7.1 requires careful experimental design:

  • Model membrane systems:

    • Liposomes with compositions mimicking bacterial versus mammalian membranes

    • Supported lipid bilayers for surface-sensitive techniques

    • Giant unilamellar vesicles for real-time microscopy observations

  • Biophysical techniques:

    • Surface plasmon resonance for binding kinetics

    • Atomic force microscopy for visualizing membrane disruption

    • Fluorescence spectroscopy for monitoring membrane leakage and peptide insertion

  • Environmental factors:

    • pH range testing (5.0-8.0) to assess pH-dependent activity

    • Ionic strength variation to examine salt sensitivity

    • Temperature conditions simulating various physiological contexts

Researchers should systematically vary these parameters to build a comprehensive model of how Uperin-7.1 interacts with different membrane types, which is essential for understanding both its natural defensive role and potential therapeutic applications.

How can researchers address cytotoxicity issues during recombinant Uperin-7.1 expression?

The antimicrobial and potentially cytolytic nature of Uperin-7.1 often creates challenges during recombinant production, as the peptide may harm host cells. Successful strategies to overcome this include:

  • Fusion protein approaches: Expression of Uperin-7.1 as a fusion with carrier proteins like thioredoxin, SUMO, or GST that reduce toxicity and enhance solubility

  • Inducible expression systems: Tight regulation of expression timing to accumulate biomass before initiating peptide production

  • Secretion strategies: Directing the peptide out of the cytoplasm to reduce intracellular toxicity

  • Codon optimization: Adjusting rare codons to match host preferences while potentially reducing translation rate to allow cellular adaptation

Each strategy requires optimization, and researchers should evaluate trade-offs between expression yield, peptide activity, and purification complexity when selecting an approach.

What purification challenges are specific to recombinant Uperin-7.1 and how can they be overcome?

Purification of recombinant Uperin-7.1 presents several challenges that require specific methodological approaches:

  • Aggregation issues: Uperin-7.1's amphipathic nature can lead to aggregation during purification. This can be addressed through:

    • Inclusion of mild detergents during initial extraction steps

    • Optimization of pH conditions to minimize aggregation

    • Use of size exclusion chromatography to separate monomeric forms

  • Non-specific binding: The cationic nature of Uperin-7.1 can cause non-specific binding to purification materials and contaminants, requiring:

    • Higher salt concentrations in buffers to disrupt ionic interactions

    • Specialized chromatography resins designed for peptide purification

    • Multiple orthogonal purification steps to achieve high purity

  • Activity preservation: Maintaining biological activity throughout purification by:

    • Minimizing freeze-thaw cycles

    • Including stabilizing excipients where appropriate

    • Conducting activity assays at multiple purification stages

These methodological optimizations are critical for obtaining pure, active recombinant Uperin-7.1 suitable for detailed characterization and application studies.

How does recombinant Uperin-7.1 compare functionally to other amphibian antimicrobial peptides?

Comparative functional analysis of recombinant Uperin-7.1 with other amphibian antimicrobial peptides reveals important differences in activity profiles and mechanisms:

PeptideOrganismPrimary MechanismSpectrum of ActivityDistinguishing Features
Uperin-7.1Litoria ewingiMembrane disruptionBroad-spectrumPart of a complex peptide mixture
MagaininsXenopus laevisToroidal pore formationGram-negative bacteriaWell-characterized structure-function relationships
BombininsBombina speciesCarpet mechanismBroad-spectrumLength and composition variants
AureinsLitoria aureaBarrel-stave mechanismGram-positive bacteriaUltra-short sequences with high activity

These comparisons can guide researchers in positioning Uperin-7.1 within the broader context of amphibian host-defense peptides and potentially identifying unique properties that distinguish it from better-studied examples in the field .

What evidence supports dual functions of Uperin-7.1 beyond antimicrobial activity?

Recent evolutionary analyses of anuran skin peptides suggest that many antimicrobial peptides may serve dual roles beyond simple pathogen defense. For Uperin-7.1, researchers should consider:

  • Antipredator functions: Evidence suggests some amphibian antimicrobial peptides may act as cytolysins that enhance delivery of neuroactive peptides to predators' nervous systems

  • Wound healing properties: Some antimicrobial peptides demonstrate cell proliferation and migration effects that promote tissue repair

  • Immunomodulatory activities: Potential influence on host immune responses beyond direct antimicrobial action

  • Environmental adaptation: Correlation between peptide composition and environmental pressures faced by different L. ewingi populations

These multifunctional aspects should be systematically investigated with recombinant Uperin-7.1 to develop a comprehensive understanding of its biological roles beyond the traditional view of antimicrobial peptides as simply part of the innate immune system.

How might advanced structural biology techniques enhance our understanding of Uperin-7.1?

Emerging structural biology techniques offer unprecedented opportunities to deepen our understanding of Uperin-7.1's molecular mechanisms:

  • Cryo-electron microscopy: Could visualize membrane-bound Uperin-7.1 complexes, revealing oligomerization states during pore formation

  • Solid-state NMR spectroscopy: Offers insights into peptide orientation and dynamics within membrane environments

  • Molecular dynamics simulations: Can model the energetics and kinetics of Uperin-7.1 membrane interactions across microsecond timescales

  • Native mass spectrometry: May identify specific lipid interactions that influence antimicrobial selectivity

These advanced techniques, when applied to recombinant Uperin-7.1, could resolve longstanding questions about its mechanism of action and guide rational design of optimized variants for research applications.

What methodological approaches can elucidate the ecological significance of Uperin-7.1 in Litoria ewingi populations?

Understanding the ecological role of Uperin-7.1 requires interdisciplinary methodological approaches:

  • Field sampling across identified genetic lineages: Collecting skin secretion samples from different L. ewingi populations, including the newly described Litoria calliscelis and Litoria sibilus species

  • Microbiome analysis: Characterizing the skin microbiome of different populations to correlate with Uperin-7.1 variants and activity profiles

  • Environmental challenge experiments: Exposing frogs to different pathogen pressures under controlled conditions to monitor Uperin-7.1 expression

  • Predator-prey interaction studies: Examining how Uperin-7.1 may function alongside other skin peptides in deterring predators

These ecological approaches, combined with molecular and biochemical characterization of recombinant variants, would provide a comprehensive framework for understanding the evolutionary significance of Uperin-7.1 in amphibian defense systems.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.